Matches in Nanopublications for { ?s ?p "Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.